Study shows that severe COVID-19 elevates the long-term risk of major adverse cardiac events (MACE), making it comparable to coronary artery disease. It also highlights a genetic interaction with ABO blood type, influencing cardiovascular outcomes.
Optimizing Clinical Trials with AI and Data-Driven Insights
Sujay Jadhav, CEO of Verana Health While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power